NEKTAR THERAPEUTICS
Recent Filings
All 1,001 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| 10-K | 10-K | Mar 13, 2026 |
| 144 | — | Mar 13, 2026 |
| 8-K | CURRENT REPORT | Mar 12, 2026 |
| SCHEDULE 13G | — | Mar 6, 2026 |
| 4 | 4 | Feb 20, 2026 |
| 4 | 4 | Feb 20, 2026 |
| 144 | — | Feb 18, 2026 |
| 144 | — | Feb 18, 2026 |
| SCHEDULE 13G/A | — | Feb 13, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| Zalevsky Jonathan | Chief R&D Officer | Award / Grant | 6,250 | Dec 22, 2025 |
| ROBIN HOWARD W | President & CEO | Award / Grant | 21,667 | Dec 22, 2025 |
| Zalevsky Jonathan | Chief R&D Officer | Award / Grant | 2,666 | Nov 25, 2025 |
| ROBIN HOWARD W | President & CEO | Award / Grant | 7,110 | Nov 25, 2025 |
| Wilson Mark Andrew | Chief Legal Officer | Sale | 630 @ $54.28 | Nov 21, 2025 |
| ROBIN HOWARD W | President & CEO | Sale | 1,210 @ $48.18 | Sep 9, 2025 |
| Zalevsky Jonathan | Chief R&D Officer | Sale | 432 @ $33.60 | Sep 4, 2025 |
| ROBIN HOWARD W | President & CEO | Sale | 1,136 @ $39.89 | Sep 4, 2025 |
| Zalevsky Jonathan | Chief R&D Officer | Sale | 485 @ $30.10 | Sep 2, 2025 |
| ROBIN HOWARD W | President & CEO | Sale | 1,500 @ $30.16 | Sep 2, 2025 |